Cardio Diagnostics (CDIO)

• Market cap: $6.43M
• 1 day: -4.86%
• 5 days: -7.61%
• 1 month: -5.88%
• 3 months: -7.12%
• 6 months: -10.89%
• Year to date: -86.58%
• 1 year: -90.22%
• 5 years: -98.81%
• 10 years: -98.81%
• Sector: Healthcare
• Industry: Biotechnology

About: Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Employees: 9